Sinopia Biosciences, Inc.
PrivateLast Round
Seed Round
Jul 16, 2026
Total Funding Raised
$7.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sinopia Biosciences, Inc. is a biotechnology company that develops novel therapeutics using its proprietary LEADS drug discovery platform, which integrates high-throughput omics data, AI/machine learning, and network analysis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sinopia Biosciences, Inc. Comparables
Compare Sinopia Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verge Labs | 80% | |
| Aitia | 79% | |
| Genesis Molecular AI | 78% | |
Sinopia Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 16, 2026 | ||||
| Grant | Mar 24, 2026 | ||||
| Grant | Dec 30, 2025 | ||||
| Grant | Sep 12, 2024 | ||||
| Grant | Apr 19, 2023 | ||||
Grant | Sep 27, 2021 |
Key People
Founding team and executive leadership
Sinopia Biosciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Received grant funding from the National Cancer Institute.
- Apr 19, 2023
$2M grant from The Michael J. Fox Foundation
Sinopia Biosciences, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sinopia Biosciences, Inc.'s valuation, stock price, and market status.